Secondly, although our data strongly suggest that ANGPTL2 promotes VEGF-A-mediated lymphangiogenesis in human lung cancer cells, we cannot exclude the possibility that ANGPTL2 also promotes the activities of other angiogenetic factors. The gene discussed is VEGFA; the disease is lung carcinoma.